Bridget E. Shields, MD

Department of Dermatology, University of Wisconsin, Madison, Wisconsin

Misha Rosenbach, MD

Department of Dermatology, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Zoe Brown-Joel, BS

University of Iowa Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa

Anthony P. Berger, MD

Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa

Bradley A. Ford, MD, PhD

Department of Pathology and Clinical Microbiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa

Karolyn A. Wanat, MD

Department of Dermatology, Pathology, and Infectious Diseases, University of Iowa, Iowa City, Iowa

Accredited by

American Academy of Dermatology

Course Description

Angioinvasive fungal infections cause significant morbidity and mortality because of their propensity to invade blood vessel walls, resulting in catastrophic tissue ischemia, infarct, and necrosis. While occasionally seen in immunocompetent hosts, opportunistic fungi are emerging in immunosuppressed hosts, including patients with hematologic malignancy, AIDS, organ transplant, and poorly controlled diabetes mellitus. The widespread use of antifungal prophylaxis has led to an “arms race” of emerging fungal resistance patterns. As the at-risk population expands and new antifungal resistance patterns develop, it is critical for dermatologists to understand and recognize angioinvasive fungal pathogens, because they are often the first to encounter the cutaneous manifestations of these diseases. Rapid clinical recognition, histopathologic, and culture confirmation can help render a timely, accurate diagnosis to ensure immediate medical and surgical intervention. Superficial dermatophyte infections and deep fungal infections, such as blastomycosis and histoplasmosis, have been well characterized within the dermatologic literature, and therefore this article will focus on the severe infections acquired by angioinvasive fungal species, including an update on new and emerging pathogens. In the first article in this continuing medical education series, we review the epidemiology and cutaneous manifestations. The second article in the series focuses on diagnosis, treatment, and complications of these infections.

Activity Details

Credit Types:CME / MOC
Credit Amount:1.00 Credits
Release Date:2019-Apr-01
Expiration Date:2022-Apr-01
Estimated Time for Completion:1 hour
Registration Required:Yes
System Requirements:
CME is free with premium AAD membership.
CME can be purchased individually for $35.95.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.